Vectored Immunoprophylaxis May Be a Valuable Tool in the Fight Against HIV/AIDS
Researchers assessed whether adeno-associated virus vectored immunoprophylaxis with AAV8-VRC07 produces broadly neutralizing antibodies in patients with HIV.
Infections In Immunocompromised Patients
COVID-19 mRNA-1273 Vaccine Preferred for Immunocompromised Patients
Researchers compared immune responses following COVID-19 vaccination with the mRNA-1273 vs the BNT162b2 vaccines among patients with rheumatic and musculoskeletal diseases and solid organ transplant recipients.
COVID-19 Booster Response in Patients With Predominant Antibody Deficiency
Researchers conducted a study to assess the effect of COVID-19 vaccination and subsequent immune responses among patients with predominant antibody deficiency.
Efficacy of COVID-19 Vaccination Significantly Differs by Immunocompromised Condition
Researchers performed a meta-analysis that assessed seroconversion rates associated with COVID-19 vaccination among patients with immunocompromised conditions.
Maternal Vaccination May Prevent Compromised Immunity in HIV-Exposed Children
Researchers evaluated the placental antibody transfer function between women with and without HIV infection and its relationship with compromised neonatal immunity.
Delayed Mortality Due to COVID-19 Among Recipients of Solid Organ Transplant
Researchers conducted a study to assess outcomes of mortality associated with COVID-19 infection among patients who previously underwent solid organ transplantation.
Immunogenicity of COVID-19 Vaccines Among Immunocompromised Individuals
Do immunocompromised individuals produce antibodies after receipt of an RNA-based COVID-19 vaccination?
Third COVID-19 Vaccine Dose May Induce Response in Subset of Patients With Chronic Lymphocytic Leukemia
Researchers sought to determine whether a third dose of the BNT162b2 mRNA vaccine against COVID-19 may induce an antibody response in patients with CLL or SLL.
ACP Releases Updated Practice Points on the Role of Natural Immunity in COVID-19
The American College of Physicians has released version 2 of their rapid, living practice points to summarize currently available evidence on the antibody response and natural immunity conferred by prior COVID-19 infection.
The Seventh Update of the WHO’s Living Guideline on COVID-19 Therapeutics
The World Health Organization assess the use of Janus kinase inhibitors and monoclonal antibodies in the seventh update of their living guideline on COVID-19 therapeutics.
- Loading...
Loading...
Loading... 
Loading...